{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:22:49Z","timestamp":1781360569342,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Patients with inflammatory bowel disease (IBD) are at increased risk of developing acute pancreatitis (AP). Thiopurines (TP) are a well-known cause of AP. The aims of this study were to compare the incidence of AP and TP-induced AP (TIP) between patients with and without IBD under the use of TP and to assess for risk factors of TIP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We examined a retrospective cohort of 664 patients treated with TP from 2016 to 2021 at our institution. AP was defined as pancreatitis confirmed by symptoms, serum tests, and radiology, and TIP as AP occurring shortly after starting TP and improving after withdrawal. We compared the incidence of AP and TIP between patients with and without IBD and reviewed the clinical features of TIP patients in detail.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 366 IBD patients and 298 without IBD. IBD patients included 249 males (52.4%) with a median age of 39 years. Among them, 211 had ulcerative colitis (UC) and 155 had Crohn\u2019s disease (CD). Azathioprine was administered to 560 patients, and 6-mercaptopurine to 104. AP occurred in 13 IBD patients but in none without IBD, with a significantly higher incidence in IBD patients (1.9% vs. 0%, P\u2005=\u2005.009). Seven of 13 patients with AP satisfied the criteria for TIP. Furthermore, 5 of the 7 TIP patients had a prior history of 5-aminosalicylic acid (5-ASA) intolerance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>TIP may be a condition specific to IBD. IBD patients with 5-ASA intolerance are prone to TIP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/crocol\/otae072","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:35:56Z","timestamp":1738251356000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical Features of Thiopurine-Induced Acute Pancreatitis: Comparison Between Patients With and Without Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-767X","authenticated-orcid":false,"given":"Tomofumi","family":"Oizumi","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University , Yahaba, Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Toya","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University , Yahaba, Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Yanai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University , Yahaba, Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-3854","authenticated-orcid":false,"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University , Yahaba, Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"6","key":"2025020608213509300_CIT0001","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med."},{"issue":"6","key":"2025020608213509300_CIT0002","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J Gastroenterol."},{"issue":"12","key":"2025020608213509300_CIT0003","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/01.mib.0000186485.30623.ad","article-title":"Acute pancreatitis in patients with Crohn\u2019s disease: clinical features and outcomes","volume":"11","author":"Moolsintong","year":"2005","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025020608213509300_CIT0004","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology."},{"issue":"1","key":"2025020608213509300_CIT0005","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulverative colitis: Medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025020608213509300_CIT0006","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: Medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2025020608213509300_CIT0007","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00228-002-0471-4","article-title":"A Swedish case-control network for studies of drug-induced morbidity-acute pancreatitis","volume":"58","author":"Blomgren","year":"2002","journal-title":"Eur J Clin Pharmacol."},{"issue":"12","key":"2025020608213509300_CIT0008","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1007\/s10620-005-3056-0","article-title":"Pancreatic autoantibodies in Greek patients with inflammatory bowel disease","volume":"50","author":"Koutroubakis","year":"2005","journal-title":"Dig Dis Sci."},{"issue":"3","key":"2025020608213509300_CIT0009","first-page":"283","article-title":"Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn\u2019s disease","volume":"9","author":"Weersma","year":"2008","journal-title":"JOP"},{"issue":"5","key":"2025020608213509300_CIT0010","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2036.2008.03746.x","article-title":"Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis","volume":"28","author":"Bermejo","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"2025020608213509300_CIT0011","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pan.2020.04.013","article-title":"Japan Pancreas Society. Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016","volume-title":"Pancreatology","author":"Masamune","year":"2020"},{"issue":"4","key":"2025020608213509300_CIT0012","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/ajg.2011.67","article-title":"Efficacy of 5-aminosalicylates in ulcerative colitis: Systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2025020608213509300_CIT0013","doi-asserted-by":"publisher","first-page":"CD004118","DOI":"10.1002\/14651858","article-title":"Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","volume":"11","author":"Marshall","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"2025020608213509300_CIT0014","doi-asserted-by":"publisher","first-page":"CD000543","DOI":"10.1002\/14651858","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"10","author":"Feagan","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"2025020608213509300_CIT0015","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/apt.13190","article-title":"Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn\u2019s disease","volume":"41","author":"Moja","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"2025020608213509300_CIT0016","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.pan.2023.06.003","article-title":"Drug-induces acute pancreatitis due to medications used for inflammatory bowel disease: A VigiBase pharmacovigilance database study","volume":"23","author":"Lee","year":"2023","journal-title":"Pancreatology"},{"issue":"1","key":"2025020608213509300_CIT0017","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ibd\/izab004","article-title":"Genetic background of mesalamine-induced fever and diarrhea in Japanese patients with inflammatory bowel disease","volume":"5","author":"Suzuki","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025020608213509300_CIT0018","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1365-2036.2010.04287.x","article-title":"Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon","volume":"31","author":"Van Geenen","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"issue":"8","key":"2025020608213509300_CIT0019","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2036.2004.02197.x","article-title":"Increased incidence of azathioprine-induced pancreatitis in Crohn\u2019s disease compared with other diseases","volume":"20","author":"Weersma","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"2025020608213509300_CIT0020","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jhbp.259","article-title":"Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines 2015","volume":"22","author":"Yokoe","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"10","key":"2025020608213509300_CIT0021","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/jhbp.1146","article-title":"JPN clinical practice guidelines 2021 with easy-to-understand explanations for the management of acute pancreatitis","volume":"29","author":"Takada","year":"2022","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"2025020608213509300_CIT0022","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/jgh.15138","article-title":"Multicenter survey on mesalamine intolerance in patients with ulcerative colitis","volume":"36","author":"Hiraoka","year":"2021","journal-title":"J Gastroenterol Hepatol."},{"issue":"4","key":"2025020608213509300_CIT0023","doi-asserted-by":"publisher","first-page":"e0231883","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe","year":"2020","journal-title":"PLoS One."},{"issue":"2","key":"2025020608213509300_CIT0024","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10620-021-06899-2","article-title":"Pancreatic disorders in patients with inflammatory bowel disease","volume":"67","author":"Montenegro","year":"2022","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2025020608213509300_CIT0025","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/flgastro-2020-101405","article-title":"Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn\u2019s disease: a systematic review","volume":"12","author":"Gordon","year":"2020","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"2025020608213509300_CIT0026","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ecco-jcc\/jjv188","article-title":"Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases\u2014a prospective study on incidence and severity","volume":"10","author":"Teich","year":"2016","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2025020608213509300_CIT0027","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1586\/17474124.2015.992879","article-title":"Thiopurine-induced pancreatitis in inflammatory bowel diseases","volume":"9","author":"Ledder","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"2025020608213509300_CIT0028","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.3093","article-title":"HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants","volume":"46","author":"Heap","year":"2014","journal-title":"Nat Genet."},{"issue":"2","key":"2025020608213509300_CIT0029","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5217\/ir.2018.16.2.273","article-title":"Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy","volume":"16","author":"Saito","year":"2018","journal-title":"Intest Res"},{"issue":"1","key":"2025020608213509300_CIT0030","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"2025020608213509300_CIT0031","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1346-8138.2010.01142.x","article-title":"Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity","volume":"38","author":"Pichler","year":"2011","journal-title":"J Dermatol."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otae072\/61701447\/otae072.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/7\/1\/otae072\/61701447\/otae072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/7\/1\/otae072\/61701447\/otae072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:21:45Z","timestamp":1738830105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otae072\/7990642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,30]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otae072","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,30]]},"article-number":"otae072"}}